Neal Mody is the Managing Director of Zoic Capital. In 2014, Neal founded Zoic to address the systematic underfunding of early-stage medical technology startups. Zoic has since led multiple seed rounds for transformative healthcare companies that leverage emerging platform technologies in the life science industry. As a hands-on investor, Neal closely monitors, mentors, and supports the acceleration of Zoic’s portfolio. He has served on the Board of Directors of seven other startups and has offered guidance to over 50 healthcare companies through his role at Creative Destruction Labs.
Before Zoic, Neal co-founded Ambature in 2007, a company that has made meaningful scientific strides towards marketable, large-scale production of room-temperature superconductor material. Neal served as Ambature’s initial CEO and maintained an active managerial role until 2013. To date, Ambature holds over half of the patents (over 2000 unique claims) in the world in their respective field.